Edition:
United Kingdom

Tonghua Dongbao Pharmaceutical Co Ltd (600867.SS)

600867.SS on Shanghai Stock Exchange

17.15CNY
4:29am BST
Change (% chg)

¥0.15 (+0.88%)
Prev Close
¥17.00
Open
¥17.15
Day's High
¥17.40
Day's Low
¥17.00
Volume
17,344,470
Avg. Vol
21,544,002
52-wk High
¥20.15
52-wk Low
¥10.94

Latest Key Developments (Source: Significant Developments)

Tonghua Dongbao Pharmaceutical Plans Share Buyback Worth 100-300 Mln Yuan Within Six Months
Friday, 26 Oct 2018 

Oct 26 (Reuters) - Tonghua Dongbao Pharmaceutical Co Ltd <600867.SS>::SAYS IT PLANS TO BUY BACK 100-300 MILLION YUAN ($14.40-$43.20 million) WORTH OF SHARES WITHIN SIX MONTHS.  Full Article

Adocia And Tonghua Dongbao Announce Global Supply Agreements
Friday, 1 Jun 2018 

June 1 (Reuters) - ADOCIA SA ::ADOCIA AND TONGHUA DONGBAO ANNOUNCE GLOBAL SUPPLY AGREEMENTS FOR INSULIN LISPRO AND INSULIN GLARGINE.TONGHUA DONGBAO (THDB) WILL MANUFACTURE AND SUPPLY INSULIN GLARGINE AND INSULIN LISPRO TO ADOCIA WORLDWIDE, EXCLUDING CHINA.AGREEMENTS EXPAND PREVIOUSLY ANNOUNCED STRATEGIC ALLIANCE BETWEEN BOTH COMPANIES.  Full Article

Tonghua Dongbao Pharmaceutical will enjoy 15 pct tax preference as high-tech enterprise
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Tonghua Dongbao Pharmaceutical Co Ltd <600867.SS> ::Says it was recognized as high-tech enterprise and will enjoy a tax preference of 15 percent for three years.  Full Article

Tonghua Dongbao Pharmaceutical's 9-month net profit up 29.6 pct y/y
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Tonghua Dongbao Pharmaceutical Co Ltd <600867.SS>:Says 9-month net profit up 29.6 percent y/y at 648.6 million yuan ($97.66 million).  Full Article

Tonghua Dongbao Pharmaceutical signs new agreement on establishment of biomedicine JV
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Tonghua Dongbao Pharmaceutical Co Ltd <600867.SS> ::Says it terminates former agreement with Harmony Biopharm Ltd and a Shanghai-based biomedicine firm, and signed a new one with Dance Biopharm Holding Inc and the Shanghai-based biomedicine firm, to set up a new biomedicine JV with registered capital of 102.6 million yuan .Co will invest 46.2 million yuan and will own a 45 percent stake in JV .  Full Article